Combination of microwave ablation and ¹³¹I labeled tumor necrosis therapy chimeric antibody in the treatment of lung cancer

Microwave ablation(MWA)has been considered as an advanced, minimally invasive technique in the treatment of lung cancer with a high local efficiency. MWA can inactivate tumor cells based on microwave heating mechanisms. It has a high local control rate of primary peripheral lung cancer and metastatic lung cancer result from percutaneous microwave antennas injection under ultrasound, CT and MRI guidance. However, for the lesions those are greater than 3.0 cm in diameter or abutting the hilars and the diffuse lesions there is less effective. ¹³¹I labeled tumor necrosis therapy chimeric antibody (¹³¹I-chTNT), a novel radioimmunotherapy which uses cell of degeneration or necrotic tumor cell nuclear antigen as target provides a new therapeutic approach for lung cancer, but the complete response is low. MWA can induce a mass tumor necrosis under the action of microwave thermal effect which greatly increases the targeting area for ¹³¹I-chTNT radioimmunotherapy. Therefore, combination of MWA and ¹³¹I-chTNT will enhance the treatment efficacy of lung cancer.